← Leaderboards
Luca Cucullo
Cleveland Clinic Lerner Com-Cwru
$4,690,569
Attributed
$7,903,224
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2011–24$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,903,224 · 3
By mechanism
R01$7,903,224 · 3
Top collaborators
- Thomas J Abbruscato15 shared
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- Serpil C. Erzurum$45,061,611
Others in their field
Top investigators on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Michael W Weiner · Northern California Institute Res &Educ$149,959,854
- David A Bennett · Rush University Medical Center$148,375,056
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$114,442,832
- Hongkui Zeng · Allen Institute$113,960,965
Research focus
BrainSmokerResponseInflammatory ResponseVascular Endothelial DysfunctionImpairmentNicotineReactive Oxygen SpeciesInflammationStrokeIn VivoToxic EffectIn VitroChronicDoseBrain InjuriesInflammatoryProteinsBlood - Brain Barrier AnatomyTobacco SmokeSmokingEdemaCerebral IschemiaElectronic Cigarette
Grant awards (21)
Repurposing Metformin to Offset Stroke Risk and Injury in Comorbid Populations of Smokers$568,452
R01 · FY2024 · NS
Repurposing Metformin to Offset Stroke Risk and Injury in Comorbid Populations of Smokers$586,033
R01 · FY2023 · NS
Repurposing Metformin to Offset Stroke Risk and Injury in Comorbid Populations of Smokers$586,033
R01 · FY2022 · NS
Repurposing Metformin to Offset Stroke Risk and Injury in Comorbid Populations of Smokers$586,033
R01 · FY2021 · NS
Blood and Brain Based Biomarkers of Injury to Assess the Cerebrovascular Impact of Emerging Alternatives to Classic Cigarette Products$450,440
R01 · FY2021 · DA
Testing Tobacco Smoke and e-Cigarette Toxicity at the Blood-Brain Barrier$382,500
R01 · FY2021 · DA
Repurposing Metformin to Offset Stroke Risk and Injury in Comorbid Populations of Smokers$595,334
R01 · FY2020 · NS
Blood and Brain Based Biomarkers of Injury to Assess the Cerebrovascular Impact of Emerging Alternatives to Classic Cigarette Products$454,762
R01 · FY2020 · DA
Testing Tobacco Smoke and e-Cigarette Toxicity at the Blood-Brain Barrier$382,500
R01 · FY2020 · DA
Testing Tobacco Smoke and e-Cigarette Toxicity at the Blood-Brain Barrier$113,362
R01 · FY2020 · DA · contact PI
Blood and Brain Based Biomarkers of Injury to Assess the Cerebrovascular Impact of Emerging Alternatives to Classic Cigarette Products$459,000
R01 · FY2019 · DA · contact PI
Testing Tobacco Smoke and e-Cigarette Toxicity at the Blood-Brain Barrier$382,500
R01 · FY2019 · DA · contact PI
Investigations into the effects of sex and age on tobacco smoke and e-Cigarette toxicity at the blood-brain barrier and stroke outcome.$113,362
R01 · FY2019 · DA · contact PI
Testing Tobacco Smoke and e-Cigarette Toxicity at the Blood-Brain Barrier$382,500
R01 · FY2018 · DA · contact PI
Testing Tobacco Smoke and e-Cigarette Toxicity at the Blood-Brain Barrier$382,500
R01 · FY2017 · DA · contact PI
Testing tobacco smoke toxicity at the blood-brain barrier$292,545
R01 · FY2015 · DA · contact PI
Testing tobacco smoke toxicity at the blood-brain barrier$297,000
R01 · FY2014 · DA · contact PI
Testing tobacco smoke toxicity at the blood-brain barrier$285,120
R01 · FY2013 · DA · contact PI
Testing tobacco smoke toxicity at the blood-brain barrier$297,000
R01 · FY2012 · DA · contact PI
Testing tobacco smoke toxicity at the blood-brain barrier$224,718
R01 · FY2011 · DA · contact PI
Testing tobacco smoke toxicity at the blood-brain barrier$81,530
R01 · FY2011 · DA · contact PI